Literature DB >> 24791521

[Research of Chinese medicine pairs (VIII)--Salviae Miltiorrhizae Radix et Rhizoma-Carthami flos].

Shu-Jiao Li, Yu-Ping Tang, Juan Shen, Jian-Ping Li, Jian-Ming Guo, Jin-Ao Duan.   

Abstract

Salviae Miltiorrhizae Radix et Rhizoma-Carthami Flos is a famous Chinese medicine pair (CMP). Salviae Miltiorrhizae Radix et Rhizoma can promote blood circulation for removing blood stasis, and Carthami Flos can promote blood circulation for removing meridian obstruction and remove blood stasis for relieving pain. The two herbs are important TCMs for activating blood. Danhong injection is the classic application of the two herbs compatibility, which was made from Salviae Miltiorrhizae Radix et Rhizoma and Carthami Flos with scientific formalation by extraction and refining. The CMP is used for treatement of organ flood insufficiency and ischemic infarction diseases. It can obviously relieving symptoms of angina pectoris, improve myocardial ischemia, regress atherosclerosis plaque, and inhibit thrombus. This paper elaberated the bio-active constituents, compatibility effects and action mechanism, and clinical applications of the CMP in order to further upgrade basic research and application levels of the CMP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24791521

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.

Authors:  Tianxin Hu; Guo Wei; Miaomiao Xi; Jiajia Yan; Xiaoxiao Wu; Yanhua Wang; Yanrong Zhu; Chao Wang; Aidong Wen
Journal:  Int J Mol Med       Date:  2016-05-11       Impact factor: 4.101

2.  Comparative Pharmacokinetics of Hydrophilic Components in Salvia miltiorrhiza Bge. and Carthamus tinctorius L. in Rats That Underwent Cerebral Ischemia Reperfusion Using an HPLC-DAD Method.

Authors:  Xixi Zhao; Li Yu; Yulin Chen; Yu Wang; Haitong Wan; Jiehong Yang
Journal:  Front Pharmacol       Date:  2020-01-24       Impact factor: 5.810

Review 3.  Danhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.

Authors:  Pengda Liao; Lei Wang; Liheng Guo; Ruixiang Zeng; Juming Huang; Minzhou Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-14       Impact factor: 2.629

4.  Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases.

Authors:  Xue-Lin Li; Jin-Fa Tang; Wei-Xia Li; Chun-Xiao Li; Tao Zhao; Bu-Chang Zhao; Yong Wang; Hui Zhang; Xiao-Fei Chen; Tao Xu; Ming-Jun Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-05       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.